Metraipolis › archive › dc_070bbf469296

Prognostic Value of NT-proBNP in Patients Treated With Allogeneic Stem Cell Transplantation — Europe PMC PMID:41385884

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41385884
DOI
10.1016/j.jacadv.2025.102415
License (as archived)
solo-consultazione
Archived
2026-11-07T17:35:29.873Z
SHA-256 of the archived text
1004956ea2f8ff38d201e1d57b168498fbd52cc8c6c34471dda3eb236cbe7ca0
Stable URL of this page
https://metraipolis.com/documento/dc_070bbf469296

How to cite

Prognostic Value of NT-proBNP in Patients Treated With Allogeneic Stem Cell Transplantation — Europe PMC PMID:41385884 — Europe PMC (en), https://europepmc.org/article/MED/41385884 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_070bbf469296 (Metraipolis archive dc_070bbf469296, sha256 1004956ea2f8ff38d201e1d57b168498fbd52cc8c6c34471dda3eb236cbe7ca0)
BibTeX
@misc{dc070bbf469296,
  title = {Prognostic Value of NT-proBNP in Patients Treated With Allogeneic Stem Cell Transplantation — Europe PMC PMID:41385884},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41385884},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_070bbf469296; sha256 1004956ea2f8ff38d201e1d57b168498fbd52cc8c6c34471dda3eb236cbe7ca0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41385884. Agents can read the archived copy with the MCP tool read_document.